News & Events
  • NaMESA Career Talk – “Toxicology, It is not just an Adventure”- Feb 11th (Tuesday), 4:30 PM

    Dr. Michael V. Templin - “Toxicology, It is not just an adventure…”. 

    Refreshments will be provided.

     Location: MoLES 315

    Date & Time: February 11th, Tuesday, 4:30 PM

    Speaker: Dr. Michael V. Templin, PhD, DABT, SNBL USA 

       Mike Templin completed under graduate (BS Pharmacy) and graduate (PhD Pharmacology/Toxicology) degrees at Washington State University. His graduate work involved research on the mechanisms of carcinogenesis for chlorinated compounds in drinking water; Post doctoral work, at the Chemical Industry Institute of Toxicology (now The Hamner Institute for Health Sciences), involved modeling of cellular toxicity and cell proliferation as a mechanism for carcinogenesis. 

       Mike has worked in the Biotech industry for more than 15 years, the last 12 years in the Seattle area. While in the Pacific Northwest he has worked as a toxicologist in Research & Development groups for Immunex (now Amgen), ZymoGenetics, and Marina Biotech. His responsibilities have included oversight of in vitro and in vivo pharmacology, toxicology, and pharmacokinetics for therapeutic drug candidates; Program Lead for development candidates and Executive Sponsor for research candidates; Design and monitoring of nonclinical studies of development candidates for IND and NDA filing; and Liaison for toxicology/preclinical development to internal and collaborative project teams. 

       Mike currently is a Technical Director for SNBL USA (Everett WA) where he has responsibility for assisting biotechnology and pharmaceutical companies in study design/conduct and in establishing nonclinical development programs for drug candidates. In his career to date Mike has had direct management and oversight of scientists at the doctoral, masters, and bachelor levels and supervision of non-science personnel. He has extensive experience in written and oral communication to the general community, industry peers, executive management (internal and external), investment community, and regulatory authorities.